Business US
Eli Lilly, Novo Nordisk Stocks Drop. Trump Targets Ozempic, ‘Fat Loss’ Drug Prices. – Barron’s
- Eli Lilly, Novo Nordisk Stocks Drop. Trump Targets Ozempic, ‘Fat Loss’ Drug Prices. Barron’s
- Ozempic, Wegovy stocks wilt following Trump GLP-1 comments Axios
- Novo Nordisk Shares Fall as Trump Moves to Cut Price of Weight-Loss Drugs The Wall Street Journal
- Eli Lilly and Novo Nordisk stocks fall as Trump says he wants $150 price for GLP-1s CNBC
- Trump says Ozempic prices will be ‘much lower’ for Americans Fox Business
